CJC-1295 (w/ DAC)
GHRH analog with Drug Affinity Complex
99%+ Pure$40
Product Description
CJC-1295 with DAC (Drug Affinity Complex) is a tetrasubstituted Growth Hormone Releasing Hormone (GHRH) analogue conjugated with a DAC moiety that extends its half-life to approximately 6–8 days. This prolonged activity makes CJC-1295 w/ DAC particularly valuable for research protocols requiring sustained, continuous GH-axis stimulation rather than pulsatile release patterns.
Expert Insight
“The DAC modification represents a significant pharmacokinetic advancement—extending half-life from minutes to days. This makes CJC-1295 w/ DAC the preferred tool for researchers studying sustained GH elevation and chronic adaptation, distinct from the pulsatile release pattern of the No DAC variant.”
Research Pairing Suggestions
This is a foundational pairing in growth hormone axis research—CJC-1295 stimulates GHRH while Ipamorelin acts as a ghrelin receptor agonist, providing dual-pathway stimulation of GH secretion.
Both are GHRH analogs with different pharmacokinetics—CJC-1295 offers longer baseline elevation while Tesamorelin provides extended duration, useful in research comparing GH secretion patterns.
Research Highlights
DAC moiety extends half-life to ~6–8 days for sustained GH-axis activation
Extensively studied in peer-reviewed GH-axis research
Synergistic effects with GHRP compounds in combination protocols
This calculator is a math tool only. It does not provide medical advice. Vital Peptides Labs sells research peptides for laboratory and research use only. Users are strongly encouraged to read the linked research, consult qualified professionals, and draw their own conclusions before making any decisions.
Reconstitution Calculator— CJC-1295 (w/ DAC)
Research Literature — CJC-1295
The following is a summary of published research literature. This information is provided for educational reference only and does not constitute medical advice or research amount guidance.
Research Amounts in Literature
In published studies, researchers have administered CJC-1295 at doses of 30–60 µg/kg or approximately 1–2 mg per administration in adult models. Common research protocols reference 100–300 µg per administration for the DAC variant.
Frequency Protocols in Research
Researchers studying CJC-1295 (no DAC) have commonly used 1–3 administrations daily, typically before sleep or fasting. CJC-1295 with DAC protocols use once or twice weekly dosing due to extended half-life.
Reconstitution Concentrations in Research
Published literature reports reconstitution of 5 mg vials in 2.5–5 mL bacteriostatic water, yielding concentrations of 1–2 mg/mL. Using 5 mL (1 mg/mL) provides easier dose measurement for the small µg-level doses used in research.
Typical Syringe Ranges in Research
At 1 mg/mL (5 mL water), a 100 µg dose equals 10 units (0.1 mL). Typical research administration volumes range from 10–30 units.
CJC-1295 (w/ DAC)
Add to your order
Pairs Well With
You'll Also Need
3mL / 23G Reconstitution Syringe
For mixing bacteriostatic water into lyophilized peptide vials
~$10–15
Buy on Amazon31G Research Syringe
For precise subcutaneous administration in research protocols
~$12–18
Buy on AmazonAlcohol Prep Pads
For sterilizing vial stoppers and work surfaces
~$5–8
Buy on AmazonBacteriostatic Water (10mL)
Sterile water with 0.9% benzyl alcohol for reconstitution
$10
ViewThis product is intended strictly for laboratory research and development purposes only. Not for human consumption, medical, veterinary, or household use. By purchasing this product, you confirm that you are at least 21 years of age and that the product will be used solely for legitimate research purposes.